Sign up to access all valuation multiples
Pihlajalinna Oyj is a private provider of healthcare and wellbeing services in Finland. The company is engaged in the business of providing healthcare and social care services to municipalities, hospital districts, companies, insurance companies, and private persons. The service selection includes general practitioner and medical specialist services, occupational healthcare, social and healthcare outsourcing, fitness center services, responsible doctor, and remote consultation services as well as residential services and staffing services.
2014
4.4K+
LTM Revenue $798M
LTM EBITDA $127M
$606M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pihlajalinna has a last 12-month revenue (LTM) of $798M and a last 12-month EBITDA of $127M.
In the most recent fiscal year, Pihlajalinna achieved revenue of $818M and an EBITDA of $118M.
Pihlajalinna expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pihlajalinna valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $798M | XXX | $818M | XXX | XXX | XXX |
| Gross Profit | $350M | XXX | $585M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $127M | XXX | $118M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $65.2M | XXX | $53.0M | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $41.3M | XXX | $31.8M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 3, 2025, Pihlajalinna's stock price is EUR 16 (or $19).
Pihlajalinna has current market cap of EUR 365M (or $424M), and EV of EUR 522M (or $606M).
See Pihlajalinna trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $606M | $424M | XXX | XXX | XXX | XXX | $1.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 3, 2025, Pihlajalinna has market cap of $424M and EV of $606M.
Pihlajalinna's trades at 0.7x EV/Revenue multiple, and 5.1x EV/EBITDA.
Equity research analysts estimate Pihlajalinna's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pihlajalinna has a P/E ratio of 10.3x.
See valuation multiples for Pihlajalinna and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $424M | XXX | $424M | XXX | XXX | XXX |
| EV (current) | $606M | XXX | $606M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 4.8x | XXX | 5.1x | XXX | XXX | XXX |
| EV/EBIT | 9.3x | XXX | 11.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.3x | XXX | 13.4x | XXX | XXX | XXX |
| EV/FCF | 8.5x | XXX | 5.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPihlajalinna's last 12 month revenue growth is -8%
Pihlajalinna's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Pihlajalinna's rule of 40 is 2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pihlajalinna's rule of X is -4% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pihlajalinna and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -8% | XXX | -7% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | 2% | XXX | 6% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -4% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pihlajalinna acquired XXX companies to date.
Last acquisition by Pihlajalinna was XXXXXXXX, XXXXX XXXXX XXXXXX . Pihlajalinna acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Pihlajalinna founded? | Pihlajalinna was founded in 2014. |
| Where is Pihlajalinna headquartered? | Pihlajalinna is headquartered in Finland. |
| How many employees does Pihlajalinna have? | As of today, Pihlajalinna has 4.4K+ employees. |
| Is Pihlajalinna publicy listed? | Yes, Pihlajalinna is a public company listed on HEL. |
| What is the stock symbol of Pihlajalinna? | Pihlajalinna trades under PIHLIS ticker. |
| When did Pihlajalinna go public? | Pihlajalinna went public in 2015. |
| Who are competitors of Pihlajalinna? | Similar companies to Pihlajalinna include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Pihlajalinna? | Pihlajalinna's current market cap is $424M |
| What is the current revenue of Pihlajalinna? | Pihlajalinna's last 12 months revenue is $798M. |
| What is the current revenue growth of Pihlajalinna? | Pihlajalinna revenue growth (NTM/LTM) is -8%. |
| What is the current EV/Revenue multiple of Pihlajalinna? | Current revenue multiple of Pihlajalinna is 0.8x. |
| Is Pihlajalinna profitable? | Yes, Pihlajalinna is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pihlajalinna? | Pihlajalinna's last 12 months EBITDA is $127M. |
| What is Pihlajalinna's EBITDA margin? | Pihlajalinna's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Pihlajalinna? | Current EBITDA multiple of Pihlajalinna is 4.8x. |
| What is the current FCF of Pihlajalinna? | Pihlajalinna's last 12 months FCF is $71.1M. |
| What is Pihlajalinna's FCF margin? | Pihlajalinna's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Pihlajalinna? | Current FCF multiple of Pihlajalinna is 8.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
